Ambu A/S
AMBBY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.52B
Close$
$5.31
59.8% downside
Current Fair Value
59.8% downsideOvervalued by 59.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.52 Billion |
|---|---|
| Enterprise Value | $3.39 Billion |
| Annual dividend | $0.06 |
| Dividend yield | 0.50% |
| Earnings per Share | $2.15 |
| Beta | 1.43 |
| Outstanding Shares | 266,555,404 |
Return
| Return on Equity | 8.27% |
|---|---|
| Return on Assets | 6.56% |
| Return on Invested Capital | 10.53% |
Valuation & Multiples
| P/E Ratio | 42.51 |
|---|---|
| PEG | 158.46 |
| Price to Sales | 0.57 |
| Price to Book Ratio | 0.57 |
| Enterprise Value to Revenue | 0.54 |
| Enterprise Value to EBIT | 4.83 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 25, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$253.28 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Ambu A/S
5,384 employees
CEO: Britt Meelby Jensen
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Vi...